ArticleExperimental hematology & oncology2024

Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors.

Chenfei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.